Literature DB >> 27320493

High levels of self-reported prescription opioid use by HIV-positive individuals.

Abigail Norris Turner1, Courtney Maierhofer1, Nicholas T Funderburg2, Brandon Snyder1, Kristi Small1, Jan Clark1, Jose A Bazan1, Nicole C Kwiek3, Jesse J Kwiek4,5.   

Abstract

Prescription medication use (other than antiretroviral therapy (ART)) is highly prevalent among people living with HIV. Prescription medications may be used medically or non-medically: non-medical use includes using more medication than prescribed, using medication prescribed to someone else, or using medication for a purpose other than its prescribed use. During 12 weeks in 2014-2015, we characterized medical and non-medical prescription medication use among HIV-positive patients attending an academic medical center (n = 149) and a community clinic (n = 105). Separately for the past year and the past month, these 254 participants self-reported their use of prescription opioids, sedatives, stimulants, anti-anxiety medications, antipsychotic medications, and erectile dysfunction medications. Respondents were largely male (91%), aged 40 or older (61%), identified as gay or bisexual (79%), and were men who have sex with men (85%). ART use was nearly universal (95%). Nearly half (43%) of participants reported medical use of prescription opioids; 11% of the opioid use was reported as non-medical use. Anti-anxiety medication use was also frequent, and differed by site: 41% of community-clinic responders reported medical use of anti-anxiety medications compared to 23% of hospital clinic respondents who reported medical use. Prescription sedative use was also approximately twice as high among community-clinic participants, with medical use reported by 43% of respondents and non-medical use by 12%; in comparison, at the hospital clinic, sedative use was reported by 18% (medical) and 7% (non-medical) of participants. Stimulant use was rare in both sites. No demographic characteristic was significantly associated with medical or non-medical use of any prescription medication. The current focus of many studies on only non-medical prescription medication use not only underestimates the widespread exposure of HIV-positive individuals to these drugs, but may also underestimate potential adverse effects of prescription medications in this population.

Entities:  

Keywords:  ART; HIV; medical use; non-medical use; opioids; prescription medication

Mesh:

Substances:

Year:  2016        PMID: 27320493      PMCID: PMC5137247          DOI: 10.1080/09540121.2016.1198746

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  23 in total

1.  Prescription opioid analgesic use among adults: United States, 1999-2012.

Authors:  Steven M Frenk; Kathryn S Porter; Leonard J Paulozzi
Journal:  NCHS Data Brief       Date:  2015-02

Review 2.  Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis.

Authors:  Anupam Banerjee; Marianne Strazza; Brian Wigdahl; Vanessa Pirrone; Olimpia Meucci; Michael R Nonnemacher
Journal:  J Neurovirol       Date:  2011-07-07       Impact factor: 2.643

3.  Drug use and medication adherence among HIV-1 infected individuals.

Authors:  Charles H Hinkin; Terry R Barclay; Steven A Castellon; Andrew J Levine; Ramani S Durvasula; Sarah D Marion; Hector F Myers; Douglas Longshore
Journal:  AIDS Behav       Date:  2007-03

4.  Substance use and sexual risk behavior in HIV-positive men who have sex with men: an episode-level analysis.

Authors:  Melissa R Boone; Stephanie H Cook; Patrick Wilson
Journal:  AIDS Behav       Date:  2013-06

5.  Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir.

Authors:  Tuija H Nieminen; Nora M Hagelberg; Teijo I Saari; Mikko Neuvonen; Pertti J Neuvonen; Kari Laine; Klaus T Olkkola
Journal:  Eur J Clin Pharmacol       Date:  2010-08-10       Impact factor: 2.953

6.  Subtypes of nonmedical prescription drug misuse.

Authors:  Sean Esteban McCabe; Carol J Boyd; Christian J Teter
Journal:  Drug Alcohol Depend       Date:  2009-03-10       Impact factor: 4.492

Review 7.  Variations in sexual risks in drug users: emerging themes in a behavioral context.

Authors:  David D Celentano; Amanda D Latimore; Shruti H Mehta
Journal:  Curr HIV/AIDS Rep       Date:  2008-11       Impact factor: 5.071

8.  Pain treatment and antiretroviral medication adherence among vulnerable HIV-positive patients.

Authors:  Hilary L Surratt; Steven P Kurtz; Maria A Levi-Minzi; Theodore J Cicero; Kiyomi Tsuyuki; Catherine L O'Grady
Journal:  AIDS Patient Care STDS       Date:  2014-07-01       Impact factor: 5.078

9.  Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis.

Authors:  Pouya Azar; Evan Wood; Paul Nguyen; Maxo Luma; Julio Montaner; Thomas Kerr; M-J Milloy
Journal:  BMC Infect Dis       Date:  2015-04-18       Impact factor: 3.090

10.  The effects of opioids on HIV reactivation in latently-infected T-lymphoblasts.

Authors:  Johannes Prottengeier; Eleni Koutsilieri; Carsten Scheller
Journal:  AIDS Res Ther       Date:  2014-07-02       Impact factor: 2.250

View more
  9 in total

1.  Study protocol for the targeting effective analgesia in clinics for HIV (TEACH) study - a cluster randomized controlled trial and parallel cohort to increase guideline concordant care for long-term opioid therapy among people living with HIV.

Authors:  Marlene C Lira; Judith I Tsui; Jane M Liebschutz; Jonathan Colasanti; Christin Root; Debbie M Cheng; Alexander Y Walley; Meg Sullivan; Christopher Shanahan; Kristen O'Connor; Catherine Abrams; Leah S Forman; Christine Chaisson; Carly Bridden; Melissa C Podolsky; Kishna Outlaw; Catherine E Harris; Wendy S Armstrong; Carlos Del Rio; Jeffrey H Samet
Journal:  HIV Res Clin Pract       Date:  2019-04

Review 2.  Synthetic Opioid Use and Common Injection-associated Viruses: Expanding the Translational Research Agenda.

Authors:  Jason T Blackard; Jennifer L Brown; Michael S Lyons
Journal:  Curr HIV Res       Date:  2019       Impact factor: 1.581

3.  Use of Nonantiretroviral Medications That May Impact Neurocognition: Patterns and Predictors in a Large, Long-Term HIV Cohort Study.

Authors:  Kendra K Radtke; Peter Bacchetti; Kathryn Anastos; Daniel Merenstein; Howard Crystal; Roksana Karim; Kathleen M Weber; Andrew Edmonds; Anandi N Sheth; Margaret A Fischl; David Vance; Ruth M Greenblatt; Leah H Rubin
Journal:  J Acquir Immune Defic Syndr       Date:  2018-06-01       Impact factor: 3.731

4.  Opioid Misuse Among HIV-Positive Adults in Medical Care: Results From the Medical Monitoring Project, 2009-2014.

Authors:  Ansley Lemons; Nicholas DeGroote; Alejandro Peréz; Jason Craw; Margaret Nyaku; Dita Broz; Christine L Mattson; Linda Beer
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731

5.  Opioid misuse among persons with HIV engaged in care in the Southeastern US.

Authors:  Asher J Schranz; Thibaut Davy-Mendez; Joseph J Eron; Sonia Napravnik
Journal:  AIDS Care       Date:  2019-12-08

6.  Are sleep patterns influenced by race/ethnicity - a marker of relative advantage or disadvantage? Evidence to date.

Authors:  Dayna A Johnson; Chandra L Jackson; Natasha J Williams; Carmela Alcántara
Journal:  Nat Sci Sleep       Date:  2019-07-23

7.  Prevalence and correlates of prescription drug diversion and misuse among people living with HIV in the eThekwini district, KwaZulu-Natal, South Africa.

Authors:  Buyisile Chibi; Nonhlanhla Yende-Zuma; Tivani P Mashamba-Thompson
Journal:  PLoS One       Date:  2020-12-16       Impact factor: 3.240

8.  Trajectories of Self-Reported Opioid Use Among Patients With HIV Engaged in Care: Results From a National Cohort Study.

Authors:  E Jennifer Edelman; Yu Li; Declan Barry; Jennifer Brennan Braden; Stephen Crystal; Robert D Kerns; Julie R Gaither; Kirsha S Gordon; Ajay Manhapra; Jessica S Merlin; Brent A Moore; Benjamin J Oldfield; Lesley S Park; Christopher T Rentsch; Melissa Skanderson; Emily C Williams; Amy C Justice; Janet P Tate; William C Becker; Brandon D L Marshall
Journal:  J Acquir Immune Defic Syndr       Date:  2020-05-01       Impact factor: 3.771

9.  Association Between Diagnoses of Chronic Noncancer Pain, Substance Use Disorder, and HIV-Related Outcomes in People Living With HIV.

Authors:  Cecile M Denis; Knashawn H Morales; Qufei Wu; David S Metzger; Martin D Cheatle
Journal:  J Acquir Immune Defic Syndr       Date:  2019-12-01       Impact factor: 3.731

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.